Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.

Paula M Fracasso; Lori J Goldstein; Dinesh P de Alwis; Janet S Rader; Matthew A Arquette; Sherry A Goodner; Lisa P Wright; Carole L Fears; Robert J Gazak; Valerie A M Andre

doi:10.1158/1078-0432.CCR-04-0452

Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.

Identifier:nobleid.org/w1/20260515/BAD141DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BAD141DF.svg?ark=w1%2F20260515%2FBAD141DF)](https://nobleid.org/work/w1/20260515/BAD141DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.

Identifier:nobleid.org/w1/20260515/BAD141DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BAD141DF.svg?ark=w1%2F20260515%2FBAD141DF)](https://nobleid.org/work/w1/20260515/BAD141DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work